Non-positive Airway Pressure Therapies for Obstructive Sleep Apnoea and Central Sleep Apnoea. (PubMed, Card Fail Rev) - Sep 24, 2026 - "In the case of tirzepatide, the Food and Drug Administration recently approved this medication for the treatment of moderate-to-severe sleep apnoea in people with obesity. However, further data are required regarding how best to improve both subjective and objective hard outcomes in people with congestive heart failure and sleep-disordered breathing."
Journal • Review • Cardiovascular • CNS Disorders • Congestive Heart Failure • Fatigue • Genetic Disorders • Heart Failure • Respiratory Diseases • Sleep Apnea • Sleep Disorder
|
|
Atul Malhotra; Bernie Sunwoo; Jorge Mora; Matheus Ramsis
|